BSE Live
Oct 13, 16:01Prev. Close
37.76
Open Price
37.68
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Profit & Loss account of Vivo Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 46.67 | 44.88 | 51.62 | 51.39 | 51.78 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 46.67 | 44.88 | 51.62 | 51.39 | 51.78 | |
Total Operating Revenues | 46.67 | 44.88 | 51.62 | 51.39 | 51.78 | |
Other Income | 4.80 | 0.04 | 0.04 | 0.09 | 0.08 | |
Total Revenue | 51.48 | 44.92 | 51.66 | 51.48 | 51.85 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 4.81 | 4.65 | 4.93 | 7.97 | 9.91 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 0.98 | -0.80 | 1.84 | 3.47 | -2.70 | |
Employee Benefit Expenses | 11.86 | 10.13 | 13.15 | 9.42 | 8.57 | |
Finance Costs | 7.50 | 7.78 | 7.65 | 3.99 | 3.53 | |
Depreciation And Amortisation Expenses | 9.02 | 9.29 | 9.27 | 7.44 | 5.59 | |
Other Expenses | 8.22 | 9.81 | 10.22 | 14.72 | 18.33 | |
Total Expenses | 42.40 | 40.86 | 47.05 | 47.01 | 43.23 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 9.08 | 4.05 | 4.61 | 4.47 | 8.62 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 9.08 | 4.05 | 4.61 | 4.47 | 8.62 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 1.51 | 1.68 | 1.03 | 0.76 | 1.36 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | -0.14 | 0.94 | 1.51 | 1.58 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 1.51 | 1.53 | 1.97 | 2.27 | 2.94 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 7.57 | 2.52 | 2.63 | 2.20 | 5.68 | |
Profit/Loss From Continuing Operations | 7.57 | 2.52 | 2.63 | 2.20 | 5.68 | |
Profit/Loss For The Period | 7.57 | 2.52 | 2.63 | 2.20 | 5.68 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 4.95 | 1.69 | 1.77 | 1.56 | 4.41 | |
Diluted EPS (Rs.) | 4.95 | 1.51 | 1.77 | 1.56 | 4.23 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
20.05.2025
Vivo Biotech Consolidated March 2025 Net Sales at Rs 12.29 crore, up 4.53% Y-o-Y
20.05.2025
Vivo Biotech Standalone March 2025 Net Sales at Rs 12.29 crore, up 6.41% Y-o-Y
13.01.2025
Vivo Biotech Consolidated December 2024 Net Sales at Rs 12.21 crore, down 4.95% Y-o-Y
13.01.2025
Vivo Biotech Standalone December 2024 Net Sales at Rs 12.21 crore, down 3.88% Y-o-Y
20.05.2025
Vivo Biotech Consolidated March 2025 Net Sales at Rs 12.29 crore, up 4.53% Y-o-Y
20.05.2025
Vivo Biotech Standalone March 2025 Net Sales at Rs 12.29 crore, up 6.41% Y-o-Y
13.01.2025
Vivo Biotech Consolidated December 2024 Net Sales at Rs 12.21 crore, down 4.95% Y-o-Y
13.01.2025
Vivo Biotech Standalone December 2024 Net Sales at Rs 12.21 crore, down 3.88% Y-o-Y